Description
Zytiga (Abiraterone) 500mg
Zytiga (Abiraterone) blocks the effect of the male hormone called testosterone. This medicine is used for certain types of prostate cancer. Zytiga works by reducing androgen production in the body. Androgens are male hormones that can promote tumor growth in the prostate gland. Zytiga is used together with steroid medication (prednisone or methylprednisolone) to treat prostate cancer that has spread to other parts of the body. Zytiga is used in men whose prostate cancer cannot be treated with surgery or other medicines.
Zytiga is indicated with prednisone or prednisolone for the treatment of metastatic castration-resistant prostate cancer in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated; the treatment of metastatic castration-resistant prostate cancer in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.
This medication is used along with prednisone to treat men with prostate cancer that has spread to other areas of the body and has not responded to surgical treatment that lowers testosterone levels. Zytiga belongs to a class of drugs known as anti-androgens (anti-testosterone). Testosterone, a natural hormone, helps prostate cancer to grow and spread. Zytiga works by blocking the production of testosterone, thereby slowing the growth and spread of prostate cancer.
